Soon-Shiong’s NantKwest Climbs as $207 Million Raised in IPO

NantKwest Inc., a cancer drugmaker headed by billionaire Patrick Soon-Shiong, gained in its trading debut after raising $207 million in a larger-than-expected initial public offering.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.

You might like: